In conclusion, the in vitro studies performed on CRC cell lines suggest that healthy-donor-derived plasma exosomes with ITGAM-enhanced expression suppressed migration, invasion, and proliferation of the CRC cell line, while liver-metastatic CRC patients-derived plasma exosomes had the opposite effect and promoted the malignancy. The gene discussed is ITGAM; the disease is colorectal carcinoma.